Ciproflox-dexameth otic susp 7.5ML
Ended Awarded
- Contract number
- SPE2DB25FSWCL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,791
Award facts
- Contract value 100% obligated
- $4,791.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL with a ceiling value of $4,791.30. This is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical procurement across the Defense Health Agency and other military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supplier that has established itself as a preferred vendor for the Defense Logistics Agency's medical supply chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a child contract under the SPE2DX vehicle, this delivery order for the antibiotic-corticosteroid otic suspension supports the military healthcare mission by ensuring the availability of essential pharmaceutical products for treatment of ear infections and related conditions. The firm fixed-price structure and rapid completion timeline reflect the expedited nature of this medical supply procurement.
Quick answers
Who was awarded contract SPE2DB25FSWCL?
SPE2DB25FSWCL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FSWCL worth?
The government has obligated $4,791 on SPE2DB25FSWCL.
Is contract SPE2DB25FSWCL an order under another contract?
Yes. SPE2DB25FSWCL is a delivery order under SPE2DB25D7067, an indefinite delivery contract.
Was contract SPE2DB25FSWCL competed?
The extent of competition for SPE2DB25FSWCL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award